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Introduction
Over the last two decades lung transplantation (LT) has
become the treatment of choice for various end-stage
lung diseases. It is well-known that the majority of
patients who underwent LT experienced complications
postoperatively. Postoperative mortality has decreased
due to improved surgical techniques and intensive care.
However, very little is known about the long-term out-
come of lung transplant recipients with prolonged inten-
sive care length of stay (ICU LOS).
Objectives
To determine long-term survival after LT depending on
ICU LOS.
Methods
A retrospective review of all patients receiving LT in
Denmark in 1992-2014. The population of lung trans-
plant recipients was divided into groups with respect to
ICU LOS: 7, 14 and 28 days. Kaplan-Meier analysis was
used to compare the overall survival between groups.
Results
Lung transplantation was performed in 653 patients.
Single lung transplantation was performed in 330 cases,
double lung transplantation in 323 cases. Main indica-
tions were chronic obstructive pulmonary disease (n =
272), alpha1-antitrypsin deficiency (n = 141), cystic
fibrosis (n = 99), pulmonary fibrosis (n = 67), sarcoidosis
(n = 29), primary pulmonary hypertension (n = 14), and
other end-stage lung diseases (n = 31).
The median ICU LOS was 3 days with interquartile
range 5 and minimum-maximum 0-156 days. The med-
ian survival time (MST) for the entire series was 6.1
years.
Of the 637 patients who survived the first 7 days after
LT, 155 (24%) had ICU LOS more than 7 days. The
MST in this group was 3.6 years compared with
7.4 years in the group of patients with ICU LOS ≤ 7
days (p < 0.001) (Figure 1).
Of 631 patients who survived the first 14 days after LT,
85 (13%) had ICU LOS more than 14 days. The MST in
this group was 2.4 years compared with 7.4 years in the
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group of patients with ICU LOS ≤ 14 days (p < 0.001)
(Figure 2).
Of 614 patients who survived the first 28 days after
LT, 43 (7%) had ICU LOS more than 28 days. The MST
in this group was 1.0 year compared with 7.0 years in
the group of patients with ICU LOS ≤ 28 days (p <
0.001) (Figure 3).
Conclusions
A significant number of LT recipients required pro-
longed ICU LOS postoperatively. The prolonged ICU
LOS was associated with poor long-term survival.
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